MiR-466 Inhibits the Progression of Severe Hepatocellular Carcinoma via Regulating FMNL2-Mediated Activation of NF-κB and Wnt/β-Catenin Pathways

Figure 5

FMNL2 could reverse the effects of miR-466 on NF-κB and Wnt/β-catenin pathways in Huh7 cells. (a) The relative expression level of miR-466 tested by qRT-PCR. (b–g) The relative expression levels of FMNL2, P65, p-P65, Wnt, and β-catenin measured by Western blot. , .

(a)

(b)

(c)

(d)

(e)

(f)

(g)